With the advent of modern medicine and technology there has been great interest in understanding how natural substances that have been consumed for thousands of years affect the human physiology and molecular machinery.
Browsing: Taxonomy > Clinical trials
Cell-free DNA (cfDNA) is a promising, noninvasive tumor ‘liquid biopsy’ with quantitative and qualitative significance.
Colon cancer is the third most common cancer worldwide.
Many new particle therapy centers are now under construction all over the world.
Primary mediastinal B-cell lymphoma (PMBL) is a subtype of diffuse large B-cell lymphoma (DLBCL) that arises in the thymus .
Often in clinical practice, dose modifications in the form of dose reductions or delays are warranted in response to treatment-related toxicity with systemic therapy administration [1,2].
The P4 paradigm for future medicine promises changes in cancer management with improved Prediction of treatment response, Prevention of disease, Personalization of therapy, and Participation by patients.
Since gemcitabine was first established as a standard treatment for unresectable pancreatic cancer in the 1990s, various chemotherapeutic regimens for pancreatic cancer have been investigated in Phase III studies.
Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, USA, 31 May–4 June 2013
Worldwide earlier diagnosis and improvement in treatment modalities gained a huge amelioration of clinical results for locally advanced rectal cancer (i.e., T3, T4 and/or nodal positive clinical presentations) in the last three decades, but still there is urgency for further improvement; moreover, there are some controversies regarding the preferable clinical management. Radiotherapy currently plays a central role in primary treatment [1,2].